1. Home
  2. SINT vs PULM Comparison

SINT vs PULM Comparison

Compare SINT & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$2.72

Market Cap

11.7M

Sector

Health Care

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$2.06

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
PULM
Founded
1996
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7M
9.4M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
SINT
PULM
Price
$2.72
$2.06
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
30.8K
43.2K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
$2,887,000.00
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$80.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.90
5069.93
52 Week Low
$1.72
$1.63
52 Week High
$6.78
$9.37

Technical Indicators

Market Signals
Indicator
SINT
PULM
Relative Strength Index (RSI) 35.28 37.45
Support Level $2.55 N/A
Resistance Level $2.94 $5.05
Average True Range (ATR) 0.13 0.27
MACD 0.00 -0.08
Stochastic Oscillator 9.26 22.60

Price Performance

Historical Comparison
SINT
PULM

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: